Drug repurposing of ERK inhibitors to target the transcription factor Nfix in dystrophic muscles: development of a new proof-of-concept study to hinder Muscular Dystrophies (1° anno)

Principal Investigators:

• GRAZIELLA MESSINA

Financing institution:

AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES

Type:

INTLI - Finanziamenti internazionali

Project leader:

UNIVERSITA' DEGLI STUDI DI MILANO

Year:

2020

Duration:

12

Status:

Closed